Dr. Lourido Salas received her Biology Degree at the University of A Coruña in 2008. After graduation, she obtained a MSc Degree in Biomedicine at University of Barcelona. In 2010, she joined the Proteomics Unit from GIR, at INIBIC, as a PhD student, earning her PhD in Biological Sciences by the University of A Coruña, in 2015. Her thesis work was mainly focused on the search for potential biomarkers of osteoarthritis by using different proteomic technologies, based on mass spectrometry and protein arrays. During her PhD, she did several internships at the Centro de Investigación del Cancer of Salamanca (Spain) and at the Royal Institute of Technology (KTH), in Stockholm (Sweden), where she learnt how to apply the most advanced protein microarrays technologies in biomedical research.

In 2016, she earned a three-year postdoctoral fellowship funded by the Xunta de Galicia (IN606B- 2016/2005) and did an internship of two years at the Affinity Proteomics Division, at the KTH-Science for Life Laboratory of Stockholm, led by Professor Peter Nilsson. Since January 2020, she has a Sara Borrell fellowship (CD19/00229), funded by the Instituto de Salud Carlos III (ISCIII).

Currently, she is responsible for the development of strategies of personalized medicine, based on immunoassays, to validate circulating biomarkers predictive of therapeutic response, which can be useful for the selection and optimization of biological therapies in rheumatoid arthritis.

She is the author or co-author of 17 scientific publications indexed in JCR- listed journals and she has an H index (WoS) of 10. She collaborates with national research groups from ISCIII: PRB3 and RIER. She is a Member of the Spanish Society of Proteomics (SeProt) and the Spanish Society of Rheumatology (SER). She also collaborates as a Lecturer in Proteomics within official Master Degree Courses, at the University of A Coruña.